However, considering the chronic administration of Teriparatide in low concentration doses in patients with osteoporosis, and even the individual genetic profile and pathologies, which cause different concentrations on the physiological production of PTH production, orthodontic patients may present different responses to applied forces, requiring major attention of the Orthodontists in face of the patient’s clinical status. This evidence concerns the gene PTH and osteoporosis.